COVID-19 Convalescent Plasma Therapy: Long-term Implications.

Hyunah YoonYi LiKeith S GoldfeldGia F CobbCaroline L Sturm-ReganatoLuis Ostrosky-ZeichnerDushyantha T JayaweeraJulie V PhilleyMahalia S DesruisseauxMarla J KellerJudith S HochmanLiise-Anne Pirofski Mila Brum Ortigozanull null

Published in: Open forum infectious diseases (2023)

CCP demonstrated no lasting effect on PASC symptoms or overall health in comparison to the placebo. This study underscores the significance of demographic factors, including sex, age, and timing of acute infection, in influencing symptom reporting 18 months after acute hypoxic COVID-19 hospitalization.

Keyphrases

coronavirus disease
sars cov
healthcare
public health
liver failure
mental health
respiratory failure
respiratory syndrome coronavirus
stem cells
health information
physical activity
aortic dissection
human health
cell therapy
acute respiratory distress syndrome
chemotherapy induced